Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 25,958 | 18,940 | 14,602 | 17,533 | 9,368 |
| Operating Income | -25,958 | -18,940 | -14,602 | -17,533 | -9,368 |
| Other Income | 123 | 10 | 10 | 4 | -10,341 |
| Pre-tax Income | -25,835 | -18,930 | -14,592 | -17,529 | -19,709 |
| Net Income Continuous | -25,835 | -18,930 | -14,592 | -17,529 | -19,709 |
| Net Income | $-25,835 | $-18,930 | $-14,592 | $-17,529 | $-19,709 |
| EPS Basic Total Ops | -3.36 | 49.20 | -1.96 | -24.14 | -40.24 |
| EPS Basic Continuous Ops | -3.35 | 49.20 | -1.94 | -24.11 | -40.27 |
| EPS Diluted Total Ops | -3.36 | 49.20 | -1.96 | -24.14 | -40.24 |
| EPS Diluted Continuous Ops | -3.35 | 49.20 | -1.94 | -24.11 | -40.27 |
| EBITDA(a) | $-25,473 | $-18,610 | $-14,404 | $-17,417 | $-9,278 |